{
    "root": "3ec2a1ae-4ca9-43b3-a3e2-2b79c2a34172",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "FERRIPROX",
    "value": "20250522",
    "ingredients": [
        {
            "name": "DEFERIPRONE",
            "code": "2BTY8KH53L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_68554"
        },
        {
            "name": "Water",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "Hydroxyethyl Cellulose (2000 Cps At 1%)",
            "code": "S38J6RZN16",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11602"
        },
        {
            "name": "Glycerin",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "Hydrochloric Acid",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "Peppermint Oil",
            "code": "AV092KU4JH",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11198"
        },
        {
            "name": "Fd&C Yellow No. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "Sucralose",
            "code": "96K6UQ3ZD4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32159"
        }
    ],
    "indications": {
        "text": "ferriprox oral solution indicated treatment transfusional iron overload adult pediatric patients 3 years age older thalassemia syndromes , sickle cell disease anemias .",
        "doid_entities": [
            {
                "text": "thalassemia (DOID:10241)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10241"
            },
            {
                "text": "sickle cell disease (DOID:0081445)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0081445"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "25 mg/kg 33 mg/kg actual body weight , orally , three times per day , total daily dose 75 mg/kg 99 mg/kg body weight . ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "ferriprox\u00ae oral solution ( deferiprone ) provided amber polyethylene terephthalate ( pet ) bottles child resistant closures ( polypropylene ) . pack contains one bottle 500 ml oral solution graduated measuring cup ( polypropylene ) . oral solution , 100 mg/ml ( 50 g/500 ml ) , ndc 10122-101-50 store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . store original bottle carton protect light . first opening bottle , discard unused portion 35 days .",
    "adverseReactions": "ferriprox contraindicated patients known hypersensitivity deferiprone excipients formulation . following reported association deferiprone : henoch-sch\u00f6nlein purpura ; urticaria ; periorbital edema skin rash [ ( 6.2 ) ] .",
    "indications_original": "FERRIPROX Oral Solution is indicated for the treatment of transfusional iron overload in adult and pediatric patients 3\u00a0years of age and older with thalassemia syndromes, sickle cell disease or other anemias.",
    "contraindications_original": "25\u00a0mg/kg to 33\u00a0mg/kg actual body weight, orally, three times per day, for a total daily dose of 75\u00a0mg/kg to 99 mg/kg body weight. ( 2.1 )",
    "warningsAndPrecautions_original": "FERRIPROX\u00ae Oral Solution (deferiprone) is provided in amber polyethylene terephthalate (PET) bottles with child resistant closures (polypropylene). Each pack contains one bottle of 500 mL oral solution and a graduated measuring cup (polypropylene).\n\n                  Oral solution, 100 mg/mL (50 g/500 mL), NDC 10122-101-50\n\n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature].\n\n                  Store in the original bottle and carton to protect from light.\n\n                  After first opening of the bottle, discard any unused portion after 35 days.",
    "adverseReactions_original": "FERRIPROX is contraindicated in patients with known hypersensitivity to deferiprone or to any of the excipients in the formulation. The following reactions have been reported in association with the administration of deferiprone: Henoch-Sch\u00f6nlein purpura; urticaria; and periorbital edema with skin rash [see Adverse Reactions (6.2)].",
    "drug": [
        {
            "name": "FERRIPROX",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_68554"
        }
    ]
}